William Reed Little - 20 Jul 2023 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Executive Vice President, Corporate Development & Strategy
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
20 Jul 2023
Net transactions value
$0
Form type
4
Filing time
24 Jul 2023, 17:11:40 UTC
Previous filing
12 Jun 2023
Next filing
10 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +250,526 $0.000000 250,526 20 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of June 1, 2023 (the "Vesting Commencement Date"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates.

Remarks:

Executive Vice President, Corporate Development & Strategy